Hillstream BioPharma, Inc.
HILS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $521 | $235 | $235 |
| - Cash | $7,610 | $2,242 | $1,076 | $3,559 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | -$1,721 | -$841 | -$3,325 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,067 | -$1,851 | -$2,547 | -$5,477 |
| % Margin | – | – | – | – |
| Net Income | -$2,102 | -$1,855 | -$2,542 | -$5,352 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.34 | -0.64 | -1.96 | -4.14 |
| % Growth | 46.9% | 67.3% | 52.7% | – |
| Operating Cash Flow | -$1,855 | -$1,143 | -$2,689 | -$5,017 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,855 | -$1,143 | -$2,689 | -$5,017 |